.png){kind=icon}
返回
Attention-deficit/hyperactivity disorder
.png){kind=icon}
PRE
AI
DOI：10.1038/s41572-024-00495-0.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Attention-deficit/hyperactivity disorder (ADHD; also known as hyperkinetic disorder) is a common neurodevelopmental condition that affects children and adults worldwide. ADHD has a predominantly genetic aetiology that involves common and rare genetic variants. Some environmental correlates of the disorder have been discovered but causation has been difficult to establish. The heterogeneity of the condition is evident in the diverse presentation of symptoms and levels of impairment, the numerous co-occurring mental and physical conditions, the various domains of neurocognitive impairment, and extensive minor structural and functional brain differences. The diagnosis of ADHD is reliable and valid when evaluated with standard diagnostic criteria. Curative treatments for ADHD do not exist but evidence-based treatments substantially reduce symptoms and/or functional impairment. Medications are effective for core symptoms and are usually well tolerated. Some non-pharmacological treatments are valuable, especially for improving adaptive functioning. Clinical and neurobiological research is ongoing and could lead to the creation of personalized diagnostic and therapeutic approaches for this disorder. Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that typically starts in childhood. This Primer summarizes the epidemiology, mechanisms, diagnosis and treatment of ADHD.
Keyword:
DEFICIT HYPERACTIVITY DISORDER
QUALITY-OF-LIFE
OPPOSITIONAL DEFIANT DISORDER
COGNITIVE-BEHAVIORAL THERAPY
RANDOMIZED CONTROLLED-TRIAL
MEDICATION-TREATED ADULTS
MEASUREMENT-BASED CARE
DOUBLE-BLIND
NONPHARMACOLOGICAL INTERVENTIONS
FUNCTIONAL OUTCOMES
期刊
N
IF:
60.6
论文数:
651
被引数:
3.8W
机构
查看更多机构
引用论文
Common adult psychiatric disorders in Swedish primary care where most mental health patients are treated.png)
BMC PSYCHIATRY
OAAI
BMC PSYCHIATRYIF3.6
OAAI分享收藏Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke阿托伐他汀通过抑制NADPH氧化酶衍生的超氧化物对缺血性脑卒中的保护作用
PREAI
分享收藏Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review注意缺陷/多动障碍 (ADHD) 的神经治疗: 综述CELLSOAAI
CELLSIF5.2
OAAI分享收藏
查看更多内容